Clinical Trial Update: Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of Buagafuran capsules in participants with hepatic impairment and those with normal hepatic function to inform use in generalized…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Buagafuran capsules (Buagafuran)

Snippet

Sponsor: Beijing Union Pharmaceutical Factory Ltd | Conditions: Generalized Anxiety Disorder | Phase 1 | Status: NOT_YET_RECRUITING